GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome

Leukemia Research

Volumn 29, Issue 11, 2005, Pages 1353-1356

  Pine, Sharon R ^a   Guo, Qianxu ^a   Yin, Changhong ^a   Jayabose, Somasundaram ^a   Levendoglu Tugal, Oya ^a   Ozkaynak, M Fevzi ^a   Sandoval, Claudio ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Acute megakaryoblastic leukemia; GATA1; Real time PCR; Transient leukemia

Indexed keywords

TRANSCRIPTION FACTOR GATA 1;

ARTICLE; BIOASSAY; BIOLOGICAL MONITORING; BONE MARROW; CLINICAL ARTICLE; DOWN SYNDROME; FEMALE; FOLLOW UP; GENE MUTATION; GENE SEQUENCE; HUMAN; INFANT; LEUKEMIA; MALE; MEGAKARYOBLAST; MEGAKARYOBLASTIC LEUKEMIA; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCREENING TEST; SINGLE STRAND CONFORMATION POLYMORPHISM; TRANSIENT LEUKEMIA;

CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 21; CLONING, MOLECULAR; DOWN SYNDROME; EXONS; FEMALE; GATA1 TRANSCRIPTION FACTOR; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; MALE; MUTATION; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; REMISSION INDUCTION;

EID: 24744433943     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.04.007     Document Type: Article

References (11)

1. J.K. Hitzler, J. Cheung, Y. Li, S.W. Scherer, and A. Zipursky GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome Blood 101 11 2003 4301 4304
2. K. Yumura-Yagi, J. Hara, A. Tawa, and K. Kawa-Ha Phenotypic characteristics of acute megakaryocytic leukemia and transient abnormal myelopoiesis Leuk Lymphoma 13 5-6 1994 393 400
3. N.J. Karandikar, D.B. Aquino, R.W. McKenna, and S.H. Kroft Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis Am J Clin Pathol 116 2 2001 204 210
4. J.M. Polski, C. Galambos, G.B. Gale, C.H. Dunphy, H.L. Evans, and J.R. Batanian Acute megakaryoblastic leukemia after transient myeloproliferative disorder with clonal karyotype evolution in a phenotypically normal neonate J Pediatr Hematol Oncol 24 1 2002 50 54
5. M.E. Greene, G. Mundschau, J. Wechsler, M. McDevitt, A. Gamis, and J. Karp Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome Blood Cells Mol Dis 31 3 2003 351 356
6. G. Mundschau, S. Gurbuxani, A.S. Gamis, M.E. Greene, R.J. Arceci, and J.D. Crispino Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis Blood 101 11 2003 4298 4300
7. L. Rainis, D. Bercovich, S. Strehl, A. Teigler-Schlegel, B. Stark, and J. Trka Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21 Blood 102 3 2003 981 986
8. M. Ahmed, A. Sternberg, G. Hall, A. Thomas, O. Smith, and A. O'Marcaigh Natural history of GATA1 mutations in Down syndrome Blood 103 7 2004 2480 2489
9. S.P. Mayer, J. Giamelli, C. Sandoval, A.S. Roach, O.M. Fevzi, and O. Tugal Quantitation of leukemia clone-specific antigen gene rearrangements by a single-step PCR and fluorescence-based detection method Leukemia 13 11 1999 1843 1852
10. S.R. Pine, F.H. Moy, J.L. Wiemels, R.K. Gill, O. Levendoglu-Tugal, and M.F. Ozkaynak Real-time quantitative PCR: standardized detection of minimal residual disease in pediatric acute lymphoblastic leukaemia. Polymerase chain reaction J Pediatr Hematol Oncol 25 2 2003 103 108
11. J. Wechsler, M. Greene, M.A. McDevitt, J. Anastasi, J.E. Karp, and M.M. Le Beau Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome Nat Genet 32 1 2002 148 152